Your session is about to expire
← Back to Search
Stereotactic Ablative Radiotherapy for Cancer (SABR-COMET Trial)
SABR-COMET Trial Summary
This trial will compare a new, more precise radiation treatment to chemotherapy and older radiation treatments to see if it improves survival and quality of life.
SABR-COMET Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSABR-COMET Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.SABR-COMET Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I haven't had any cancer treatment in the last 4 weeks.My treated cancer spread is under control, or if not, it can be treated with SABR after surgery.I have health conditions that prevent me from receiving radiotherapy.My cancer has spread, and imaging tests have confirmed this.I am fully active or can carry out light work.My original cancer site has been stable for at least 3 months after treatment.I have 1-3 brain tumors and no cancer in other parts of my body.I have had radiation therapy on the area that now needs treatment.I have no more than 3 cancer spread spots in any one organ.I am not a candidate for surgery to remove my cancer according to my medical team.My case was reviewed by a team of cancer specialists.My first chemotherapy fully eliminated the cancer that can be measured.I have fluid buildup due to cancer in the lining of my lung.All my cancer sites cannot be treated.I need surgery to relieve pressure in my brain from cancer.My MRI shows a tumor near my spinal cord or evidence of spinal cord compression.All my cancer sites can be safely treated.My cancer has spread to the bone in my thigh.I am 18 years old or older.
- Group 1: Stereotactic arm
- Group 2: Standard arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How does Stereotactic ablative radiotherapy affect individuals' wellbeing?
"As per our internal assessment at Power, Stereotactic ablative radiotherapy's safety level is rated 2 because this a Phase 2 trial. This indicates there are some results that demonstrate the treatment's security yet no data to support its efficacy."
Is the enrollment period for this experiment still open?
"The data hosted on clinicaltrials.gov reveals that this medical trial is not presently recruiting individuals, despite last being edited on April 5th 2022. Nevertheless, there are 637 other studies actively searching for volunteers at the present moment."
How many healthcare facilities are currently conducting this research study?
"At this time, 7 medical facilities are onboarding patients into the experiment. These locations span across Hamilton, Montreal, Vancouver and other cities in between - so try to pick an institution that is near you to limit your journey distance if deciding to sign up."
Share this study with friends
Copy Link
Messenger